
FORESITE CAPITAL MANAGEMENT IV, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | PHVS | 4.78M | $119.23M |
![]() | RLAY | 1.00M | $5.22M |
![]() | LYEL | 800K | $13.00M |
![]() | MAZE | 523K | $13.55M |
![]() | CYTK | 458K | $25.19M |
![]() | XENE | 160K | $6.42M |

Pharvaris N.V.
PHVS
Shares Held
4.78M
Value
$119.23M

Relay Therapeutics, Inc.
RLAY
Shares Held
1.00M
Value
$5.22M

Lyell Immunopharma, Inc.
LYEL
Shares Held
800K
Value
$13.00M

Maze Therapeutics, Inc.
MAZE
Shares Held
523K
Value
$13.55M

Cytokinetics, Incorporated
CYTK
Shares Held
458K
Value
$25.19M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
160K
Value
$6.42M
